Transketolase (TKT) Peptide
TKT
Reactivity: Human
Host: Synthetic
BP, IHC, WB
-
- Target See all TKT products
- TKT (Transketolase (TKT))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TKT antibody (Catalog #: ARP48540_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TKT (Transketolase (TKT))
- Background
-
TKT belongs to the transketolase family. TKT has been implicated in the latent genetic disease Wernicke-Korsakoff syndrome (WKS), which causes specific brain damage.
Alias Symbols: FLJ34765, TKT1, TK
Protein Interaction Partner: MYOC,TKT,TKT
Protein Size: 623 - Molecular Weight
- 68 kDa
- Gene ID
- 7086
- NCBI Accession
- NM_001064, NP_001055
- UniProt
- P29401
-
You are here:
